78
ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 [email protected]

ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 [email protected]

Embed Size (px)

Citation preview

Page 1: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

ICD-10-CM An Introduction 2011

Bobbi Buell, MBAonPoint Oncology [email protected]

Page 2: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• Create an awareness of ICD-10-CM.• Start to consider the impact the conversion to ICD-10 will have on your operations.

• Start to understand what it means and does not mean in Oncology.

Page 3: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Medicare Physician Fee Schedule FINAL Rule

Page 4: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL MPFS 2011

• On November 2, 2010, the Centers for Medicare & Medicaid Services (CMS) posted a proposed notice for Medicare payments in the physician fee schedule for calendar year (CY) 2011.

• Many of these provisions were specified in Health Reform (“ACA”). The final rule (CMS-1502-P) affects physicians and office payment for services paid under the resource-based relative value scale/system (RBRVS), also known as, the Medicare Physician Fee Schedule.

• Here are the highlights of Rule which becomes effective for dates of service on or after 11-2-2010.

onPoint Oncology LLC 4https://www.cms.gov/PhysicianFeeSched/PFSFRN/list.asp#TopOfPage

Page 5: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL MPFS 2011

• Practice Expense: CMS continues for the second year (at a 50/50 blend), the phasing-in over four years the implementation of the American Medical Association (AMA) Physician Practice Information Survey (PPIS) data administered in 2007/08 for practice expense (PE) indirect per hour rate. Oncology is still using the AMA SMS data series. Of interest is this year's calculation of practice expense for drug administration because many of our codes were bumped up slightly to include some supplies.

onPoint Oncology LLC 5

https://www.cms.gov/PhysicianFeeSched/PFSFRN/list.asp#TopOfPage

Page 6: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL MPFS 2011

• Related –TC of Imaging Codes Get Cuts: Well, of course, this is happening in July 2010. But, what it means is that, as of July 6, you will get a cut of 50% for secondary –TCs of related procedures in the same family of imaging procedures. This has been expanded to include more and unrelated procedures. SEE ADDENDUM F of the fee schedule for additional procedure reduction codes.

• Telehealth Services: To perform telehealth services, there must be two-way communication between provider and patient, plus you must be in HPSA (Health Provider Shortage) area or outside an MSA. Additional services proposed as allowable in 2011 are 99231-99233 (every three days) and 99307-99310 every 30 days along with services that are unrelated to Oncology.

onPoint Oncology LLC 6

Page 7: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL MPFS 2011• Physician Extenders: They are sometimes known as NPs

and PAs. They can now perform certification and periodic re-certification for SNF patients.

• Bone density payment: The proposal calls for these to be paid 70% of the 2006 RVUs at the 2006 conversion factor with this year’s GPCIs for codes 77080-77082. This is retroactive to January 1, 2010.

• Payment for Biosimilars: Here is the payment formula for drugs that are ‘similar’ to today’s biologics. Down the road, we will see lots of these in cancer treatment for sure…• A biosimilar is a product approved under an abbreviated

application for a license of a biological product that relies on a license of another biologic.

• The payment for these biosimilar products will be the sum of all ASPs assigned to a biosimilar products divided by all applicable units plus six percent of the REFERENCE PRODUCT…how does that work?

onPoint Oncology LLC 7

Page 8: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL MPFS 2011• Self-Referral Disclosure Law: Effective for dates of service

after January 1, 2011 for CAT, MRI, and PET:• A list of FIVE (not ten) alternative ‘suppliers’ (not a hospital)

within a 25-mile radius of the physician’s office who provide the same imaging services. If there are not five, you must list all.

• The list must include, name, address, phone number of other facilities. If there is no one they can go to, tell the patient they can get these tests in other facilities.

• The list is to be given to the patient at the time of referral. EACH time the patient is referred it must be given.

• No signature or form retention is required. Make a note in the chart or get a stamp for charts---but there should be a notation that it was given.

• Must be written in a way that patients can understand.• Emergency situations are not an exception.• Exceptions include patients who are not on Medicare at the

time of the referral.

onPoint Oncology LLC 8

Page 9: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL MPFS 2011• Drugs: This rule maintains the current average sales price (ASP) + 6%

reimbursement for Part B drugs; however, it includes proposed changes to ASP reporting, thresholds, and vial amounts.  • Among other provisions, if the manufacturer is late with quarterly reporting, the

CMS proposes to update ASPs by carrying over the previously reported manufacturer ASP for applicable national drug code(s) (NDC(s)). This is called the “carry over” methodology. This method will not be implemented if there are not a significant number of involved NDCs. But, manufacturers are still subject to Civil Monetary Penalties, if they make a habit of not submitting ASPs.

• CMS also proposes to update the regulations to clearly state that Medicare will not pay for amounts of “overfill”, i.e. product in excess of the amount reflected on the FDA-approved label. The ASP plus 6% will be paid for FDA-approved amounts in the vial, but practices may not bill for and/or pool their overfill.

• Partial quarter ASPs for new drugs were also discussed in the proposed rule. Single-source drugs will be priced at WAC, plus 6% for that quarter and multisource and line extension drugs will be added to the weighted average of applicable NDCs.

• CMS also proposes to maintain the applicable threshold percentage for price substitution of WAMP or AMP for two consecutive quarters at 5%. CMS also finalizes the proposal to maintain the applicable threshold percentage for price substitution at 5%, however did not finalize a new proposal for price substitution at 103% of average manufacturer price (AMP) in certain circumstances when the ASP exceeds the AMP.

onPoint Oncology LLC 9

Page 10: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

What is Overfill?

• An amount in the vial that is not indicated on the label.

• It is an amount not included in what you paid for in terms of vial size.

• Under ‘incident to’, practices may not be reimbursed for anything which does not represent an expense to them.

• Prior to the final rule, overfill was statutorily excluded from payment. But, the FR reinforced this.

onPoint Oncology LLC 10

Page 11: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL MPFS 2011

• Signature on Requisition: CMS will require a physician’s or a non-physician practitioner’s signature on requisitions for clinical diagnostic laboratory tests paid under the Clinical Lab Fee Schedule. This has gotten very negative comments in the past.• CMS believes that signatures are already required on orders for clinical

diagnostic laboratory tests paid under the Clinical Lab Fee Schedule and there is confusion about the difference between an order and a requisition.

• The proposed policy will also be consistent with the requirement that orders for diagnostic tests paid under the MPFS must be signed by a physician or appropriate non-physician practitioner.

• CMS has updated this policy to state that it will not be enforced First Quarter 2011. There are also very public rumors that this will go away.

• One-year filing for Part B claims: There has already been a transmittal about this. But, starting January 1, 2010, there will be a one-year filing deadline for claims.

onPoint Oncology LLC 11

Page 12: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL Fee Schedule 2011

• PQRI for 2011: This year, there are 194 measures in the rule. Like last year, there are 2 reporting periods: 6 months and 12 months. Other proposed changes to PQRI applicable to office-based cancer practices include:• Registries: CMS once again emphasized that Registries are the way to go for more

accuracy in PQRI data submission. CMS wants to get away from claims submissions ASAP. New cancer registry: [email protected].

• Success Criteria: It is PROPOSED for claims ONLY that you report on at least 3 measures (if applicable) AND you report on at least 50% of applicable patients, instead of 80%---which would still be the rate for EMR/EHR or Registry submission.

• Group Practices: Two types of group practices are proposed to report in 2011. First are practices over 200 eligible providers called GPROI. Then there are groups 2-199 eligible providers called GPROII. To report as a GPROII, you must self-nominate; be in the first 500 practices to do so after the beginning of the year 2011; and, you must report at least one of GPROII groups, which do not apply to many cancer practices. CMS is looking for specialty measures groups for GPROII.

• Deleted Measures: These measures used by cancer folks are leaving (maybe) in 2011:• Measures 114 and 115 for Tobacco Use (more later about this);• Measure 136 for Melanoma

• Measures Reportable by Registry Only: These are the same as last year:• 137-138: Melanoma• 143-144: Pain In Cancer Measures

onPoint Oncology LLC 12

Page 13: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL E-Prescribing 2011

• E-Prescribing: E-prescribing will pay 1% of the providers’ billed and allowed fee schedule services (all services paid by RVUs) in 2011. 2011 is the last year where you will not be penalized, if you do not participate if you qualify. BUT, 2011 is the year that those that should be penalized will be identified. The penalty only exists for those who do not have at least 100 cases in the denominator codes (mostly E/M); who do not report at least 10 encounters by mid-2011, or, do not qualify as a physician or physician extender who has at least 10% of fee schedule revenue in the denominator codes.

onPoint Oncology LLC 13

https://www.cms.gov/PhysicianFeeSched/PFSFRN/list.asp#TopOfPage

Page 14: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

E-Rx Reporting

• For successful claims-based reporting in 2011,a single code should be reported (numerator) G8553 – At least one prescription created during the encounter was generated and transmitted electronically using a qualified e-Rx system

• Must be on the same claim (denominator)–90801, 90802, 90804, 90805, 90806, 90807, 90808, 90809, 90862, 92002, 92004, 92012, 92014, 96150, 96151, 96152, 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99315, 99316, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0101, G0108, G0109

• Combination is reported on at least 25 encounters

onPoint Oncology LLC 14

Page 15: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FINAL E-Prescribing

• If you participate in the HIT incentive, you may not receive the e-prescribing incentive, but you must e-prescribe AND FOR NOW YOU MUST REPORT!

• Incentive• Reporting period: Calendar year, but data 1/1/2011-

6/30/2011 will be used to identify those who should be penalized. So, you must report at least 10 encounters per NPI before 6/30/11.

• Reporting mechanisms: CLAIMS ONLY!!• Hardship exceptions—there will be new G-codes for

these: • Rural practices with no high speed internet OR• Providers near pharmacies that do not process e-

rx.

onPoint Oncology LLC 15

Page 16: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Hospital Outpatient PPS 2011

• Drug payments– Continue standard packaging methodology for drugs under a certain benchmark.

• Drugs costing less than $70 per day are packaged into ambulatory payment classification (APC)

• Drugs costing more than $70 are reimbursed separately

• Separately billable drugs paid at ASP+5%

• Only 5-HT3 antiemetic product exempt from standard packaging methodology is palonosetron hydrochloride—used to be all 5 HT-3s

onPoint Oncology LLC 16

Page 17: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

HOPPS 2011

• Ongoing discussion about supervision requirements

• Under direct supervision CMS clarified that supervising physician or non-physician practitioner (NPP) must be “immediately available”– CMS not defining “immediately available” but referenced as physically present and interruptible.

• Varies by type of facility.

onPoint Oncology LLC 17

Page 18: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

18

HOPPS 2011• In the New Rule

• Commencing in 2010, CMS allows certain non-physician practitioners (NPPs) – example, PAs, NPs, clinical nurse specialists – to provide direct supervision for hospital outpatient therapeutic services they are authorized to perform in state scope of practice rules and under hospital privileging. Chemo requires direct supervision; other drug administration does not

• For an on-campus hospital outpatient setting the rule is met by immediate availability of either a physician or NPP anywhere on the same hospital campus and immediately available to furnish assistance and direction throughout performance of the procedure (may be in non-hospital space on the campus)

• For an off-campus outpatient department, supervising physician or NPP must be in the provided-based department (though not necessarily in the same room)

Page 19: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

FOUR BIG-TIME INITIATIVES

WILL BEGIN OR HAVE BEGUN THIS YEAR

Is Your Organization Prepared?

Page 20: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Division B, Title IV: Electronic Health Record (EHR) Installations Incentive Payments are for “Adoption and Meaningful Use of Certified EHR Technology”

*Applies to Medicare ONLY – US Hospitals

2009 ARRA / HITECH Act

I.A. Beginning in October 2010*

Medicare / Medicaid

Incentive Payments

MEANINGFUL USE of

CERTIFIED EHRsProviders / Hospitals

Page 21: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Division A, Title XIII - Subtitle D:

1996 HIPAA Title II--Administrative Simplification Standards Modifications The Confidentiality and Privacy Standards The Security Standards

*HHS’ OCR begins to enforce Privacy Rule only after a rule is in place; Privacy’s Breach Rule already in place

Applies to ALL (new / existing) HIPAA CEs

2009 ARRA / HITECH Act

I.B. Began in February 2010*

HIPAA “TWO” Confidentiality/

Privacy and

Security Standards

Page 22: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

II. Compliance on January 1, 2012

The EDI Transactions SetVersion 5010 and D.0 Transactions

Applies to ALL (new / existing) HIPAA Covered Entities and ALL Accredited Standards Committee (ASC) X12 and National Council for Prescription Drug Program (NCPDP) transactions

1996 HIPAA Title II--Administrative Simplification

Standards Modifications

Page 23: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

HIPAA 5010 COMPLIANCE DATES

HIPAA 5010 EFFECTIVE DATE: March 17, 2009

LEVEL I COMPLIANCE BY: December 31, 2010 CMS Medicare Fee-for-Service Schedule:

April 1, 2010 through December 31, 2010

LEVEL II COMPLIANCE BY: December 31, 2011 CMS Medicare Fee-for-Service Schedule:

January 1, 2011 through December 31, 2011

ALL CEs FULLY COMPLIANT ON: January 1, 2012

Page 24: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

All Other

Physician

Long Term Healthcare

Laboratory

Behavioral HealthHospital

Outpatient

ICD-10-CM / PCS

Inpatient

III. Beginning on October 1, 2013

Page 25: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

ICD-9-CM vs. ICD-10-CM

Page 26: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

1) ICD-9-CM is out of date and running out of space for new codes.

• Lacks specificity and detail• No longer reflects current medical practice

2) ICD-10 is the international standard to report and monitor diseases and mortality, making it important for the U.S. to adopt ICD-10 based classifications for reporting and surveillance.

3) ICD codes are the core elements of HIT systems, conversion to ICD-10 is necessary to fully realize benefits of HIT adoption.

Page 27: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• ICD-10-CM code book retains the same traditional format • Index

• Tabular

• Process of coding is similar• Look up a condition in the Index

• Confirm the code in the Tabular

Page 28: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

ICD – 9-CM ICD – 10-CM

13,600 codes 69,000 codes

Code book contains 17 chapters Code book contains 21 chapters

Consists of 3 to 5 characters Consists of 3 to 7 characters

1st character is alpha or numeric 1st character is alpha

Only utilizes letters E and V Utilizes all letters (except U)

Second, third, fourth, and fifth characters are always numeric

Second characteris always numeric

Third, fourth, fifth, sixth, and seventh

characters can be alpha or numeric

Shorter code descriptions because of lack of specificity and abbreviated code titles

Longer code descriptions because of greater clinical detail and

specificity and full code titles

Page 29: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

ICD-9-CM CODE• A - Category of

code

• B - Etiology, anatomical site, and manifestation

ICD-10-CM CODE• A - Category of

code

• B - Etiology, anatomical site, and/or severity

• C - Extension• 7th character for obstetrics,

injuries, and external causes of injury

A B

A B C

Page 30: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

XX .

ICD-9-CM Structure – Format

XX XX XX XX55EE 1 4 0 0.VV

Category Etiology, Anatomic Site, Manifestation

4

Numeric or Alpha

(E or V) Numeric

3 – 5 Characters

Page 31: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

XX XX XX XX

Category

.Etiology, Anatomic

Site, Severity

Added code extensions (7th character) for obstetrics, injuries, and external causes of injury

ICD-10-CM Structure – Format

XX XX XXAAMMS 3 2 0. 1 0 A

Additional Characters

Alpha (Except U)

2 - 7 Numeric or Alpha

3 – 7 Characters

Page 32: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

ICD-9-CM Codes ICD-10-CM Codes

Pressure ulcer codes 9 codes

707.00 – 707.09

Pressure ulcer codes 125 codes

L89.0-L89.94

Codes:707.0 Pressure ulcer 707.00 - unspecified site 707.01 - elbow 707.02 - upper back 707.03 - lower back 707.04 - hip 707.05 - buttock 707.06 - ankle 707.07 - heel 707.09 - other site

Code Examples:L89.131 – Pressure ulcer of right lower back, stage IL89.132 – Pressure ulcer of right lower back, stage IIL89.133 – Pressure ulcer of right lower back, stage IIIL89.134 – Pressure ulcer of right lower back, stage IVL89.139 – Pressure ulcer of right lower back, unspecified stageL89.141 – Pressure ulcer of left lower back, stage IL89.142 – Pressure ulcer of left lower back, stage IIL89.143 – Pressure ulcer of left lower back, stage IIIL89.144 – Pressure ulcer of left lower back, stage IVL89.149 – Pressure ulcer of left lower back, unspecified stageL89.151 – Pressure ulcer of sacral region, stage IL89.152 – Pressure ulcer of sacral region, stage II…L89.90 – Pressure ulcer of unspecified site, unspecified stage

Page 33: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• Combination codes for conditions and common symptoms or manifestations

• Combination codes for poisonings and external causes

• Added laterality

• Expanded codes: injury, diabetes, alcohol/substance abuse, postoperative complications

Page 34: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• Added extensions for episode of care

• Inclusion of trimester in obstetrics codes and elimination of fifth digits for episode of care

• Expanded detail relevant to ambulatory and managed care encounters

• Inclusion of clinical concepts that do not exist in ICD-9-CM

• Changes in timeframes specified in certain codes

Page 35: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Useful in Cancer??

• Laterality – Left Versus Right • C50.1 Malignant neoplasm, of central portion

of breast • C50.111 Malignant neoplasm of central

portion of right female breast • C50.112 Malignant neoplasm of central

portion of left female breast

Page 36: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Useful In Cancer???

• ICD-9-CM • 143 Malignant neoplasm of gum

• 143.0 Upper gum • 143.1 Lower gum

• ICD-10-CM • C03 Malignant neoplasm of gum

• C03.0 Malignant neoplasm of upper gum• C03.1 Malignant neoplasm of lower gum

Page 37: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

General Equivalence Mappings

Page 38: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• “GEMs” stands for General Equivalence Mappings

• The CMS and the CDC created GEMs to ensure consistent national data when the U.S. adopts ICD-10.

• The GEMs will act as a translation dictionary to bridge the “language gap” between the two code sets and can be used to map an ICD-9 code to an ICD-10 code and vice versa.

Page 39: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• Designed to give all sectors of the healthcare industry that use coded data the tools to:• Convert large databases and test system applications• Link data in long-term clinical studies• Develop application-specific mappings• Analyze data collected before and after the transition

to ICD-10-CM

Page 40: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• The GEMs should not be used as a substitute for learning how to use the ICD-10-CM code sets.• “GEMs are not a substitute for learning ICD-10-

PCS and ICD-10-CM coding. They’ll help you convert large data sets.”

• Mapping simply links concepts in the two code sets, without consideration of context of specific patient information, whereas coding involves assigning the most appropriate code based on documentation and applicable coding guidelines.

Page 41: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• A clear one-to-one correspondence between an ICD-9 or ICD-10 code is the exception rather than the rule.• ICD-9 codes: 414.01 Coronary atherosclerosis of native

coronary artery and 411.1 Intermediate coronary syndrome (unstable angina)

• ICD-10 code :I25.110 Atherosclerotic heart disease of native coronary artery with unstable angina

• There are situations when a code in the target system does not exist• T503x6A Underdosing of electrolytic, caloric and water-

balance agents, initial encounter

Page 42: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

ICD-9 Code

Description (Source)

820.8 Fracture of unspecified part of neck of femur, closed

ICD-9 Code

Description(Target)

820.8 Fracture of unspecified part of neck of femur, closed

Forward Mapping

Backward Mapping

Page 43: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

GEMS Example #1

Page 44: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

GEMS Example #2

Page 45: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

GEMS #3

Page 46: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

GEMS Example #4

Page 47: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Preparing for ICD-10

Page 48: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

48

Checklist: http://www.ahima.org/icd10/ICD-10PreparationChecklist.mht

2009/ 2010 2011 2012 2013

Awareness and Impact

Assessment Preparing for Implementation

Go Live Preparati

on

Post – Implementation

Phase I

Phase II

Phase III

Phase IV

Year

Page 49: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• The increased specificity of the ICD-10 codes requires more detailed clinical documentation in order to code some diagnoses to the highest level of specificity.

• There are “unspecified” codes in ICD-10-CM for those instances when medical record documentation is not available to support more specific codes.

• The benefits of ICD-10 can not be realized if non-specific codes are used rather than taking advantage of the specificity ICD-10 offers.

Page 50: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• Conduct medical record documentation assessments• Evaluate records to determine adequacy of

documentation to support the required level of detail in new coding systems

• Implement a documentation improvement program to address deficiencies identified during the review process• Educate providers about documentation

requirements for the new coding system through specific examples

• Emphasize the value of more concise data capture for optimal results and better data quality

Page 51: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• DHHS agrees that some physicians will want intensive training on ICD-10 but some will seek “awareness training”. • Nolan study estimates 8 hours of intensive physician

training

• Nachimson Advisors, LLC study predicts 12 hours of physician training in both the code set and documentation procedures.

• AHIMA believes most physicians would want no more than 4 hours of training.

Page 52: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Solo Practitioner Or Small Group (2-10) Practice Implementation Planning

1. Organize Implementation Effort2. Establish Communication Plan3. Conduct Impact Analysis4. Contact System Vendors5. Estimate Budget6. Implementation Planning7. Develop Training Plan8. Analyze Business Processes9. Education and Training 10. Policy Change Development 11. Deployment of Code12. Implementation Compliance

52

Page 53: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

1. Organize Implementation Effort

• Enlist staff person (coder, biller, manager) to oversee effort who will be key point person―Prepare information to share with other providers and

staff―Identify work and scope for implementation

• Should be a team effort involving all medical practice staff

53

Page 54: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

1. Organize Implementation Effort

• Look at all areas that will impact practice and identify each one that will be affected― Practice management system― Electronic Medical Record (EMR), if applicable― Super bills― Clinical areas

• Schedule regular meeting to share information with physicians and discuss progress and barriers of implementation

54

Page 55: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

2. Establish Communication Plan

• How will point person communicate with all staff?• Most small practices communicate via meetings or

memosNo need to change method of communicationsDevelop regular schedule

• Monthly until 6 months prior to implementation

• Bi-weekly thereafter

Include information, publications, and articles

55

Page 56: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

3. Conduct Impact Analysis

• Take this step prior to development of budget• In depth look at resources required for implementation

• Helps determine what costs might be involved as well as work processes

• What systems will be affected?• Practice management• Coding look up programs (if applicable)• EMR• Remittance systems• Hardware space

• What are the potential costs involved?

56

Page 57: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

3. Conduct Impact Analysis

• Develop reasonable timeline that can be accomplished in the solo or small medical practice―Map out a project plan on a simple Excel

spreadsheet with benchmarks and status of completion

• Managers and/or coders should get physician approval

57

Page 58: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Sample Project PlanItem Steps to Implementation Start Due Completed Assigned to1.0 Organize the implementation effort-

Estimated timeline 2 months1/16/09 7/1/09    

1.1 Review ICD-10 final rule 1/16/09 2/1/09 1/31/09 Manager

1.2 Point person/lead for ICD-10-CM implementation

2/1/09 3/1/09 3/1/09 Manager

1.3 Prepare briefing materials to review with physician(s) related to work and scope of work that needs to be accomplished

3/4/09 4/30/09 4/30/09 Manager

1.4 Contact our consultant to review materials and offer assistance

4/1/09 5/1/09 4/15/09 Manager

1.5 Review impact of ICD-10 with all providers 5/1/09 6/1/09 6/1/09 Manager1.6 Establish regular meeting schedule with

provider(s) to discuss progress5/15/09 6/1/09 6/1/09 Manager

1.7 Identify areas that will impact the practice 6/1/09 7/1/09   Manager and Coder

1.8 Establish who has final decision making authority

6/1/09 7/1/09   Physicians

    Start Due Completed Assigned to

2.0 Establish communication Plan 7/1/09 8/1/09   Manager

2.1 Develop method of communication on ICD-10-CM

      Manager

2.2 Develop materials for physicians and staff       Manager

2.3 Develop communication schedule       Manager

58

Page 59: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

3. Conduct Impact Analysis

• Coding and documentation go hand in hand• Based on complete and accurate documentation• ICD-10 should impact documentation as

physicians are required to support medical necessity using appropriate diagnosis code

• Will not change the way a physician practices medicine

• Complete and accurate documentation will continue to be important in 2013 as it is today

59

Page 60: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

4. Contact System Vendors

• Will they be able to accommodate the need to move to ICD-10?

• Will they be ready for 5010 on January 1, 2012?• What costs will be involved with the transition to 5010

and ICD-10?

• What plans do they have in place for implementation?

• When will they have software available for testing?

• Will we need new hardware or is current hardware sufficient?

60

Page 61: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

5. Estimate Budget

• Budget considerations should include• Hardware costs• Software costs and licensing• Training

61

Page 62: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

6. Implementation Planning

• Begin planning early in 2010

• Break down planning into stages• Training for a small practice does not need to begin

until 6 months prior to implementation

• Review super bills and remove rarely used codes

• Crosswalk common codes from ICD-9-CM to ICD-10-CM―Look up codes in ICD-10-CM book and use GEMs if

necessary

62

Page 63: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Crosswalk Example Iron Deficiency Anemia

ICD-9-CM ICD-10-CM

280 Iron deficiency anemia D50 Iron deficiency anemia

280.0 Secondary to blood loss D50.0 Secondary to blood Loss

280.1 Secondary to inadequate dietary

intake

D50.8 Other iron deficiency anemias

280.8 Other specified iron deficiency

anemias

D50.1 Sideropenic dysphagia

D50.8 Other iron deficiency anemias

280.9 Iron deficiency anemia, unspecified D50.9 Iron deficiency anemia

unspecified

63

Page 64: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

7. Develop Training Plan

• Who needs training?• Physicians• Coders• Billing staff• Administrative staff• Clinical Staff

• Required number of hours depends on their role

• What resources are available?64

Page 65: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

7. Develop Training Plan

• Many organizations will have several mechanisms for training• Distance learning• Workshops• Conferences• Audio Conferences• Webinars• Books

• Establish training schedule

65

Page 66: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

7. Develop Training Plan

• Determine if temporary staff or overtime will be necessary during training period

• What materials will the office need for ongoing support after training?• Books• Software (code look up programs)• Other

66

Page 67: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

8. Analyze Business Processes

• Identify all systems and processes that currently use ICD-9-CM

• Review existing medical policies related to ICD-9-CM

• Which contracts tied to reimbursement are tied to a particular diagnosis?

• Modify any contract agreements with health plans

67

Page 68: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

9. Education and Training

• Education should begin approximately 6 months prior to implementation

• Large practices may need to begin earlier to accommodate all staff who need training

• Use various methods of training

• Training time depends on their role

• Physicians and coders/billers will need more training time than administrative staff

68

Page 69: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

10. Policy Change Development

• After health plans complete and change medical policy for procedures and services a specialty provides• Review new payment policies• Identify opportunities to improve coding processes• Communicate policy changes to applicable staff

69

Page 70: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

11. Deployment of Code • Vendor delivers software update with

ICD-10-CM

• Vendors should• Test system• Integrate software into your systems• Make internal customizations• Test systems with clearinghouses, payers,

electronic claims transmission (end to end)• Ensure that the vendor will maintain

updates to code during transition period

70

Page 71: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

12. Implementation Compliance

• Compliance date for implementation – October 1, 2013

• Monitor compliance activities to identify any problems

71

Page 72: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

Other Considerations• Consider use of electronic tools to facilitate coding process–Could reduce costs and claims rejections–Could increase productivity and coding accuracy

• Don’t convert superbills/charge documents too early–Currently, ICD-10-CM is still updated annually– 6 –12 months prior to implementation or after

code set has been “frozen”–Assign ICD-10-CM codes directly, not by

applying ICD-9-CM to ICD-10-CM map

72

Page 73: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

CMS’ Web Resources• ICD-10 General Information

http://www.cms.hhs.gov/ICD10• ICD-10 Educational Resources (fact

sheets)http://www.cms.hhs.gov/ICD10/05_Educational_Resources.asp

• ICD-10 CMS Sponsored Calls (2008 and 2009 discussion materials and transcripts)http://www.cms.hhs.gov/ICD10/07_Sponsored_Calls.asp

73

Page 74: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

CDC’s Web Resources• General ICD-10 information

http://www.cdc.gov/nchs/about/major/dvs/icd10des.htm

• ICD-10-CM files, information, and General Equivalence Mappings (GEM) between ICD-10-CM and ICD-9-CMhttp://www.cdc.gov/nchs/about/otheract/icd9/icd10cm.htm

74

Page 75: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

AHA’s Resources• Regulatory member advisories• Presentations and articles• ICD-10 2009 audio seminar series• Central Office on ICD-9-CM

http://www.ahacentraloffice.org • AHA Central Office ICD-10 Resource Center

http://www.ahacentraloffice.org/ICD-10

75

Page 76: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

In Summary…• Part B providers must select their incentive programs

carefully this year. May not participate in E-Rx and HIT/ EHR in the same year.

• Evaluate whether your providers are going to get hit with the E-Rx penalty in 2012…time is running out.

• Update your Superbill or in HOPDs, your CDM for all J-code changes.

• Don’t think you will escape Medicare and Medicaid audits---that where ACA revenue is coming from.

• Get prepared or HIPAA 2 and 5010. ICD-10 will be coming up soon after (YUCK)…

76

Page 77: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

• CAN Web Site• The latest news• Forms• Regulations• Newsletters• Presentations• http://can.communityoncology.org

77

Page 78: ICD-10-CM An Introduction 2011 Bobbi Buell, MBA onPoint Oncology LLC 800-795-2633 bbuell@onpointoncology.cim

78

• Contact• [email protected][email protected]• 800-795-2633

• Newsletter is free!

• Send all RAC information to me at the ABOVE E-mails or FAX to 650-618-8621

• Go to our website: http://www.onpointoncology.com